Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Clinical quantification of SpO2 instability using a new histogram classification system: a clinical study.

Borenstein-Levin L, Konikoff L, Solimano A.

Pediatr Res. 2019 Sep 20. doi: 10.1038/s41390-019-0566-6. [Epub ahead of print]

PMID:
31539898
2.

RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit-successes and challenges.

Elliott AM, du Souich C, Lehman A, Guella I, Evans DM, Candido T, Tooman L, Armstrong L, Clarke L, Gibson W, Gill H, Lavoie PM, Lewis S, McKinnon ML, Nikkel SM, Patel M, Solimano A, Synnes A, Ting J, van Allen M, Christilaw J, Farrer MJ, Friedman JM, Osiovich H.

Eur J Pediatr. 2019 Aug;178(8):1207-1218. doi: 10.1007/s00431-019-03399-4. Epub 2019 Jun 7.

PMID:
31172278
3.

Dextrose gels for neonatal transitional hypoglycemia: What are we giving our babies?

Solimano A, Kwan E, Osiovich H, Dyer R, Elango R.

Paediatr Child Health. 2019 May;24(2):115-118. doi: 10.1093/pch/pxy185. Epub 2019 Feb 5.

PMID:
30996602
4.

Outcomes related to respiratory syncytial virus with an abbreviated palivizumab regimen in children with congenital heart disease: a descriptive analysis.

Claydon J, Popescu CR, Shaiba L, Christopherson C, Human D, Taylor R, Solimano A, Lavoie PM.

CMAJ Open. 2019 Feb 18;7(1):E88-E93. doi: 10.9778/cmajo.20180167. Print 2019 Jan-Mar.

5.

Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.

Mürner-Lavanchy IM, Doyle LW, Schmidt B, Roberts RS, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W, Anderson PJ; Caffeine for Apnea of Prematurity (CAP) Trial Group.

Pediatrics. 2018 May;141(5). pii: e20174047. doi: 10.1542/peds.2017-4047. Epub 2018 Apr 11.

6.

Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.

Schmidt B, Roberts RS, Anderson PJ, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Doyle LW, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity (CAP) Trial Group.

JAMA Pediatr. 2017 Jun 1;171(6):564-572. doi: 10.1001/jamapediatrics.2017.0238.

PMID:
28437520
7.

Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen.

Claydon J, Sur A, Callejas A, Ladd M, Kwan E, Taylor R, Turvey SE, Solimano A, Lavoie PM, Marr N.

PLoS One. 2017 Apr 24;12(4):e0176152. doi: 10.1371/journal.pone.0176152. eCollection 2017.

8.

Reflections on trauma, symbolization and psychic pain in a case of neurosis and a case of psychosis.

Maldonado JL, Solimano AL.

Int J Psychoanal. 2016 Oct;97(5):1299-1320. doi: 10.1111/1745-8315.12489. Epub 2016 Apr 5.

PMID:
27059446
9.

Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab.

Lavoie PM, Solimano A, Taylor R, Kwan E, Claydon J, Turvey SE, Marr N.

JAMA Pediatr. 2016 Feb;170(2):174-6. doi: 10.1001/jamapediatrics.2015.3235. No abstract available.

10.

Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.

Schmidt B, Roberts RS, Davis PG, Doyle LW, Asztalos EV, Opie G, Bairam A, Solimano A, Arnon S, Sauve RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators.

J Pediatr. 2015 Nov;167(5):982-6.e2. doi: 10.1016/j.jpeds.2015.07.067. Epub 2015 Aug 28.

PMID:
26318030
11.

Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants.

Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, Bairam A, Moddemann D, Peliowski A, Rabi Y, Solimano A, Nelson H; Canadian Oxygen Trial Investigators.

JAMA. 2015 Aug 11;314(6):595-603. doi: 10.1001/jama.2015.8841.

PMID:
26262797
12.

Association of unit size, resource utilization and occupancy with outcomes of preterm infants.

Shah PS, Mirea L, Ng E, Solimano A, Lee SK; Canadian Neonatal Network.

J Perinatol. 2015 Jul;35(7):522-9. doi: 10.1038/jp.2015.4. Epub 2015 Feb 12.

PMID:
25675049
13.

Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial.

Schmidt B, Roberts RS, Whyte RK, Asztalos EV, Poets C, Rabi Y, Solimano A, Nelson H; Canadian Oxygen Trial Group.

J Pediatr. 2014 Oct;165(4):666-71.e2. doi: 10.1016/j.jpeds.2014.05.028. Epub 2014 Jun 25.

PMID:
24973289
14.

Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years.

Schmidt B, Davis PG, Asztalos EV, Solimano A, Roberts RS.

JAMA. 2014 Feb 5;311(5):523-5. doi: 10.1001/jama.2013.282153. No abstract available.

PMID:
24496539
15.

Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.

Marr N, Wang TI, Kam SH, Hu YS, Sharma AA, Lam A, Markowski J, Solimano A, Lavoie PM, Turvey SE.

J Immunol. 2014 Feb 1;192(3):948-57. doi: 10.4049/jimmunol.1302007. Epub 2014 Jan 3.

16.

Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure.

Konduri GG, Sokol GM, Van Meurs KP, Singer J, Ambalavanan N, Lee T, Solimano A.

J Perinatol. 2013 Dec;33(12):944-9. doi: 10.1038/jp.2013.83. Epub 2013 Jul 18.

17.

Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.

Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS; Canadian Oxygen Trial (COT) Group.

JAMA. 2013 May 22;309(20):2111-20. doi: 10.1001/jama.2013.5555.

PMID:
23644995
18.

Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.

Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators.

JAMA. 2012 Jan 18;307(3):275-82. doi: 10.1001/jama.2011.2024.

PMID:
22253394
19.

[Conflict and deficit in etiopathogenia].

Solimano AL.

Vertex. 2010 Jul-Aug;21(92):245-52. Spanish.

PMID:
21188311
20.

Palivizumab for the prevention of respiratory syncytial virus infection.

Rogovik AL, Carleton B, Solimano A, Goldman RD.

Can Fam Physician. 2010 Aug;56(8):769-72.

21.

[Clinic and psychotherapy of psychosis].

Solimano AL.

Vertex. 2009 May-Jun;20(85):228-36. Spanish.

PMID:
19652779
22.

Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms.

Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B; Trial of Indomethacin Prophylaxis in Preterms Investigators.

Pediatrics. 2008 Feb;121(2):e233-8. doi: 10.1542/peds.2007-0028.

PMID:
18245398
23.

Long-term effects of caffeine therapy for apnea of prematurity.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group.

N Engl J Med. 2007 Nov 8;357(19):1893-902.

24.

Neonatal macrocephaly: cerebral primitive neuroectodermal tumor or neuroblastoma as an infrequent cause--a case report and review of the literature.

Kaczala GW, Poskitt KJ, Steinbok P, Hendson G, Eydoux P, Solimano AJ.

Am J Perinatol. 2007 Oct;24(9):507-9. Epub 2007 Oct 1. Review.

PMID:
17909991
25.

Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up.

Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A, Johnson Y; Neonatal Inhaled Nitric Oxide Study Group.

J Pediatr. 2007 Mar;150(3):235-40, 240.e1.

26.

[Bipolar disorder and psychoanalytical concepts of depression and mania].

Solimano A, Manfredi C.

Vertex. 2006 Sep-Oct;17(69):347-52. Spanish.

PMID:
17088955
27.

Caffeine therapy for apnea of prematurity.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group.

N Engl J Med. 2006 May 18;354(20):2112-21.

28.

Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit.

Khashu M, Osiovich H, Henry D, Al Khotani A, Solimano A, Speert DP.

Pediatrics. 2006 Feb;117(2):340-8.

PMID:
16452352
29.

Male/female differences in indomethacin effects in preterm infants.

Ohlsson A, Roberts RS, Schmidt B, Davis P, Moddeman D, Saigal S, Solimano A, Vincer M, Wright L; Trial Of Indomethacin Prophylaxis In Preterms Tipp Investigators.

J Pediatr. 2005 Dec;147(6):860-2.

PMID:
16356449
30.

Neonatal procedural pain exposure predicts lower cortisol and behavioral reactivity in preterm infants in the NICU.

Grunau RE, Holsti L, Haley DW, Oberlander T, Weinberg J, Solimano A, Whitfield MF, Fitzgerald C, Yu W.

Pain. 2005 Feb;113(3):293-300.

31.

A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.

Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A; Neonatal Inhaled Nitric Oxide Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):559-64.

PMID:
14993550
32.

Ibuprofen prophylaxis in preterm neonates.

Schmidt B, Wright LL, Davis P, Solimano A, Roberts RS; Indomethacin Prophylaxis in Preterms Investigators.

Lancet. 2002 Aug 10;360(9331):492. No abstract available.

PMID:
12241754
33.

Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL; Trial of Indomethacin Prophylaxis in Preterms Investigators.

N Engl J Med. 2001 Jun 28;344(26):1966-72.

34.

Resuscitation of newborns.

Niermeyer S, Van Reempts P, Kattwinkel J, Wiswell T, Burchfield D, Saugstad OD, Milner A, Knaebel S, Perlman J, Azzopardi D, Gunn A, Boyle R, Toce S, Solimano A; American Heart Association; International Liaison Committee on Resuscitation.

Ann Emerg Med. 2001 Apr;37(4 Suppl):S110-25. No abstract available.

PMID:
11290975
35.

International Guidelines for Neonatal Resuscitation: An excerpt from the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Contributors and Reviewers for the Neonatal Resuscitation Guidelines.

Niermeyer S, Kattwinkel J, Van Reempts P, Nadkarni V, Phillips B, Zideman D, Azzopardi D, Berg R, Boyle D, Boyle R, Burchfield D, Carlo W, Chameides L, Denson S, Fallat M, Gerardi M, Gunn A, Hazinski MF, Keenan W, Knaebel S, Milner A, Perlman J, Saugstad OD, Schleien C, Solimano A, Speer M, Toce S, Wiswell T, Zaritsky A.

Pediatrics. 2000 Sep;106(3):E29.

PMID:
10969113
36.

Morphine pharmacokinetics and pain assessment in premature newborns.

Scott CS, Riggs KW, Ling EW, Fitzgerald CE, Hill ML, Grunau RV, Solimano A, Craig KD.

J Pediatr. 1999 Oct;135(4):423-9.

PMID:
10518075
37.

Prenatally diagnosed fetal neck teratoma. Case report and novel management options.

Gagnon AL, Bebbington MW, Kamani A, Solimano A.

Fetal Diagn Ther. 1998 Sep-Oct;13(5):266-70.

PMID:
9813418
38.
39.

Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.

Skinner AM, Battin M, Solimano A, Daaboul J, Kitson HF.

Am J Perinatol. 1997 Oct;14(9):539-46.

PMID:
9394163
40.

The measurement of knee-heel length in newborn infants using a simple vernier calipers.

Skinner AM, Cieslak Z, MacWilliam L, Solimano A, Kitson HF.

Acta Paediatr. 1997 May;86(5):512-7.

PMID:
9183491
41.

Further case of Galloway-Mowat syndrome of abnormal gyral patterns and glomerulopathy.

Kingo AR, Battin M, Solimano A, Phang M, McGillivray B.

Am J Med Genet. 1997 Apr 14;69(4):431. No abstract available.

PMID:
9098497
42.

Effect of triamcinolone acetonide on the development of the pulmonary airways in the fetal rat.

Rotschild A, Solimano A, Sekhon HS, Massoud EA, Thurlbeck WM.

Pediatr Pulmonol. 1997 Feb;23(2):76-86.

PMID:
9065944
43.

Development of the pulmonary airways in the fetal rat and its relation to the prenatal environment.

Rotschild A, Massoud EA, Solimano A, Puterman ML, Sekhon HS, Thurlbeck WM.

Pediatr Pulmonol. 1996 Apr;21(4):219-26.

PMID:
9121850
44.

Chronic lung disease following neonatal ventilation. I. incidence in two geographically defined populations.

Fenton AC, Annich G, Mason E, Solimano A, Field DJ.

Pediatr Pulmonol. 1996 Jan;21(1):20-3.

PMID:
8776261
45.

Inhaled nitric oxide for the treatment of persistent pulmonary hypertension.

Solimano A.

West J Med. 1995 Apr;162(4):356-7. No abstract available.

46.

Mycoplasma surgical wound infection in a neonate.

Brooker RJ, Eason JD, Solimano A.

Pediatr Infect Dis J. 1994 Aug;13(8):751-3. No abstract available.

PMID:
7970983
47.

The CRIB score.

Fenton AC, Field DJ, Solimano A, Annich G.

Lancet. 1993 Sep 4;342(8871):612; author reply 613. No abstract available.

PMID:
8102735
49.

Waxing and waning hyperinflation in congenital cystic adenomatoid malformation of the lung.

Bainbridge TC, Solimano A, Rotschild A, Sharma AK, Thurlbeck W.

J Perinatol. 1992 Sep;12(3):237-9.

PMID:
1432280
50.

Midfacial hypoplasia associated with long-term intubation for bronchopulmonary dysplasia.

Rotschild A, Dison PJ, Chitayat D, Solimano A.

Am J Dis Child. 1990 Dec;144(12):1302-6.

PMID:
2244608

Supplemental Content

Loading ...
Support Center